Abstract
Pulmonary hypertension is a chronic pulmonary vascular disease. In recent years, quite a number of studies suggest that the increase of pulmonary artery pressure is the result of multiple factors. A better understanding of the related factors is of great significance to the prevention, diagnosis, treatment and prognosis of pulmonary hypertension. Based on this, this paper studies the genetic immunity and environmental induced pulmonary hypertension. In this paper, 60 patients with pulmonary hypertension in our hospital from January 2020 to the first half of July 2020 were selected as the research objects. According to the pathogenic factors, the patients were divided into groups. Among them, pulmonary hypertension caused by genetic factors was group A, and pulmonary hypertension caused by environmental factors was group B. This study found that the incidence rate of family genetic history reached 6%, and the proportion of diseases caused by immune factors accounted for 2%. Because of the high altitude hypoxia environment, about 5% accounted for 5%. Smoking is the main factor leading to the morbidity of pulmonary hypertension, accounting for up to 70%. The results of this study provide theoretical basis for the treatment of pulmonary hypertension caused by genetic immunity and environment.
Highlights
Pulmonary hypertension is a malignant progressive disease [1,2]
The main clinical manifestation of pulmonary hypertension is the gradual increase of right ventricular afterload, which leads to right heart failure and even death [3,4]
Understanding the pathogenesis and pathogenesis of pulmonary hypertension is conducive to targeted treatment
Summary
Pulmonary hypertension is a malignant progressive disease [1,2]. The main clinical manifestation of pulmonary hypertension is the gradual increase of right ventricular afterload, which leads to right heart failure and even death [3,4]. More and more studies are being carried out on the pathogenesis of pulmonary hypertension. Relevant studies have pointed out that the influencing factors of pathogenesis of pulmonary hypertension include hypoxia, genetic immunity, congenital, smoking and so on. The research on pulmonary hypertension in China has focused on the pathogenesis and diagnosis and treatment, and made significant progress [9,10]. Understanding the pathogenesis and pathogenesis of pulmonary hypertension is conducive to targeted treatment. Through the experimental study of 60 patients with pulmonary hypertension in our hospital from January to the first half of July 2020, we understand the main causes of pulmonary hypertension and the changes of physiological indicators after the onset, so as to provide theoretical data for the follow-up treatment
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
